Symptom-centric view
Inappropriate schedule of product administration
Substances reporting Inappropriate schedule of product administration disproportionately — ranked by ROR.
showing 2 of 2
| Substance ↓ | ROR [95% CI] | Reports | Category | Label |
|---|---|---|---|---|
semaglutide Ozempic · Wegovy | 4.2 [4.0–4.3] | 2,746 | glp-1 | new |
minoxidil Rogaine · Loniten | 3.3 [3.1–3.5] | 1,167 | glp-1 | new |
ROR = reporting odds ratio vs. the full FAERS corpus. A signal is not a cause. Source: openFDA (FAERS).